Literature DB >> 19918049

Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization.

Fabrizio Villa1, Paola Capasso, Marcello Tortorici, Federico Forneris, Ario de Marco, Andrea Mattevi, Andrea Musacchio.   

Abstract

Haspin, a nuclear and chromosome-associated serine/threonine (S/T) kinase, is responsible for mitotic phosphorylation of Thr-3 of histone H3. Haspin bears recognizable similarity to the eukaryotic protein kinase (ePK) fold, but its sequence is highly divergent and there is therefore considerable interest in its structural organization. We report the 2.15-A crystal structure of the kinase domain of human Haspin. The ePK fold of Haspin contains an array of insertions and deletions. The structure illustrates how Haspin escapes the classical activation scheme of most other kinases. The alphaC helix, which bears a conserved glutamate that is essential for catalysis, adopts its final active conformation within the small lobe of the kinase. It is sandwiched between an alpha-helical insertion that precedes the kinase domain, and the activation segment, which adopts an unprecedented conformation. The activation segment, which does not contain phosphorylatable residues, packs against an unusually structured alphaEF helix. Significantly extruded from the core of the fold, it forms an extensive plateau, hosting several residues implicated in substrate binding. Overall, the structure of the Haspin kinase domain reveals an active conformation that is poised for substrate recognition and phosphorylation in the absence of external regulators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918049      PMCID: PMC2777964          DOI: 10.1073/pnas.0908485106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

Review 2.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 3.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

Review 4.  Regulation of protein kinases; controlling activity through activation segment conformation.

Authors:  Brad Nolen; Susan Taylor; Gourisankar Ghosh
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

Review 5.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

6.  Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.

Authors:  F Zhang; A Strand; D Robbins; M H Cobb; E J Goldsmith
Journal:  Nature       Date:  1994-02-24       Impact factor: 49.962

7.  Cloning and characterization of human haspin gene encoding haploid germ cell-specific nuclear protein kinase.

Authors:  H Tanaka; N Iguchi; Y Nakamura; J Kohroki; C E de Carvalho; Y Nishimune
Journal:  Mol Hum Reprod       Date:  2001-03       Impact factor: 4.025

Review 8.  Structure, function and evolution of haspin and haspin-related proteins, a distinctive group of eukaryotic protein kinases.

Authors:  J M G Higgins
Journal:  Cell Mol Life Sci       Date:  2003-03       Impact factor: 9.261

9.  Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase.

Authors:  D R Knighton; J H Zheng; L F Ten Eyck; V A Ashford; N H Xuong; S S Taylor; J M Sowadski
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

10.  A conserved salt bridge in the G loop of multiple protein kinases is important for catalysis and for in vivo Lyn function.

Authors:  Rina Barouch-Bentov; Jianwei Che; Christian C Lee; Yating Yang; Ann Herman; Yong Jia; Anastasia Velentza; James Watson; Luise Sternberg; Sunjun Kim; Niusha Ziaee; Andrew Miller; Carie Jackson; Manabu Fujimoto; Mike Young; Serge Batalov; Yi Liu; Markus Warmuth; Tim Wiltshire; Michael P Cooke; Karsten Sauer
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

View more
  31 in total

1.  Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.

Authors:  Mayalen Oxoby; François Moreau; Lionel Durant; Alexis Denis; Jean-Marie Genevard; Vanida Vongsouthi; Sonia Escaich; Vincent Gerusz
Journal:  Bioorg Med Chem Lett       Date:  2010-06-15       Impact factor: 2.823

2.  Interplay among nucleosomal DNA, histone tails, and corepressor CoREST underlies LSD1-mediated H3 demethylation.

Authors:  Simona Pilotto; Valentina Speranzini; Marcello Tortorici; Dominique Durand; Alexander Fish; Sergio Valente; Federico Forneris; Antonello Mai; Titia K Sixma; Patrice Vachette; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

3.  A kinase-dependent role for Haspin in antagonizing Wapl and protecting mitotic centromere cohesion.

Authors:  Cai Liang; Qinfu Chen; Qi Yi; Miao Zhang; Haiyan Yan; Bo Zhang; Linli Zhou; Zhenlei Zhang; Feifei Qi; Sheng Ye; Fangwei Wang
Journal:  EMBO Rep       Date:  2017-11-14       Impact factor: 8.807

Review 4.  Haspin: a newly discovered regulator of mitotic chromosome behavior.

Authors:  Jonathan M G Higgins
Journal:  Chromosoma       Date:  2009-12-08       Impact factor: 4.316

5.  A positive feedback loop involving Haspin and Aurora B promotes CPC accumulation at centromeres in mitosis.

Authors:  Fangwei Wang; Natalia P Ulyanova; Maike S van der Waal; Debasis Patnaik; Susanne M A Lens; Jonathan M G Higgins
Journal:  Curr Biol       Date:  2011-06-09       Impact factor: 10.834

6.  Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors.

Authors:  Gregory D Cuny; Maxime Robin; Natalia P Ulyanova; Debasis Patnaik; Valerie Pique; Gilles Casano; Ji-Feng Liu; Xiangjie Lin; Jun Xian; Marcie A Glicksman; Ross L Stein; Jonathan M G Higgins
Journal:  Bioorg Med Chem Lett       Date:  2010-06-15       Impact factor: 2.823

7.  Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors.

Authors:  Gregory D Cuny; Natalia P Ulyanova; Debasis Patnaik; Ji-Feng Liu; Xiangjie Lin; Ken Auerbach; Soumya S Ray; Jun Xian; Marcie A Glicksman; Ross L Stein; Jonathan M G Higgins
Journal:  Bioorg Med Chem Lett       Date:  2012-01-28       Impact factor: 2.823

Review 8.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

9.  Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine.

Authors:  Stefano Santaguida; Anthony Tighe; Anna Morena D'Alise; Stephen S Taylor; Andrea Musacchio
Journal:  J Cell Biol       Date:  2010-07-12       Impact factor: 10.539

10.  Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.

Authors:  Darja Lavogina; Katrin Kestav; Apirat Chaikuad; Christina Heroven; Stefan Knapp; Asko Uri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-04-22       Impact factor: 1.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.